Did the Drug Enforcement Agency break the law and gamble with public safety when it permitted large quantities of fentanyl pills to be trafficked in New Mexico in the hopes of getting a larger drug-trafficking bust?
That is the question at the heart of an explosive story published in the Associated Press, based on information provided by a former DEA agent turned whistleblower; the whistleblower filed a complaint in 2023 that claimed agents had allowed hundreds of thousands of fentanyl pills into Albuquerque – a city still reeling from the opioid crisis while many others across the country are seeing overdose rates decline.
